Novabay Pharmaceuticals Inc Umsatz
Was ist das Umsatz von Novabay Pharmaceuticals Inc?
Umsatz von Novabay Pharmaceuticals Inc ist $12.023M
Was ist die Definition von Umsatz?
Umsatz sind die Einnahmen, die ein Unternehmen aus seiner normalen Geschäftstätigkeit erzielt, normalerweise aus dem Verkauf von Waren und Dienstleistungen an Kunden.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Umsatz von Unternehmen in Health Care Sektor auf NYSEMKT im Vergleich zu Novabay Pharmaceuticals Inc
Was macht Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Unternehmen mit umsatz ähnlich Novabay Pharmaceuticals Inc
- IDEAYA Biosciences hat Umsatz von $11.960M
- Earth Science Tech hat Umsatz von $11.960M
- Far East International hat Umsatz von HKD$11.980M
- Golden Minerals hat Umsatz von $12.000M
- Checkit plc hat Umsatz von £12.000M
- aap Implantate AG hat Umsatz von €12.004M
- Novabay Pharmaceuticals Inc hat Umsatz von $12.023M
- California Software hat Umsatz von ₨12.050M
- PyroGenesis Canada hat Umsatz von CAD$12.063M
- Biotricity hat Umsatz von $12.063M
- Otrs Ag hat Umsatz von €12.129M
- Jupiter US Smaller Cos. Plc hat Umsatz von £12.140M
- The Limestone Boat hat Umsatz von CAD$12.140M